SUBSCRIBE
SUBSCRIBE

Affini-T Therapeutics

NEWS
Business
Top Life Sciences Startups to Watch in 2023
BioSpace is proud to present its NextGen Bio “Class of 2023,” a list of the hottest recently launched life sciences companies in North America.
December 5, 2022
 · 
15 min read
 · 
BioSpace Editorial Staff
IN THE PRESS
BioForest
Affini-T Therapeutics to Present Novel CRISPR Gene Editing Data from its Oncogenic Driver Program Targeting KRAS at the American Society of Gene and Cell Therapy 26th Annual Meeting
May 9, 2023
 · 
2 min read
BioForest
Affini-T Therapeutics Announces Licensing Agreement with Memorial Sloan Kettering Cancer Center to Expand Company’s Pipeline of Oncogenic Driver Programs
April 13, 2023
 · 
4 min read
BioForest
Affini-T Therapeutics Presents Preclinical Data from its Oncogenic Driver Program Targeting KRAS at the American Association for Cancer Research (AACR) Annual Meeting 2023
April 13, 2023
 · 
4 min read
BioForest
Affini-T Therapeutics to Present Data from Lead Oncogenic Driver Candidate at AACR Special Conference: Targeting RAS
March 3, 2023
 · 
1 min read
BioForest
Affini-T Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 5, 2023
 · 
1 min read
Business
ElevateBio and Affini-T Therapeutics Announce Partnership to Advance Affini-T’s T Cell Therapy Programs Targeting Core Oncogenic Drivers
November 15, 2022
 · 
5 min read
BioForest
Affini-T Therapeutics to Present Preclinical Data from its Lead Programs Targeting KRAS G12V at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
November 7, 2022
 · 
2 min read
Load More
AWARDS
  • NextGen Class of 2023
JOBS